Clinical trial
Evaluation of Patient and Physician Reported Reasons for Switching FVIII Replacement Therapies
NCT03405337 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Patient and Physician Reported Reasons for Switching FVIII Replacement Therapies
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 14, 2018
- Completion date
- June 13, 2018
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.